A-248 Investigating Brentuximab Vedotin (BV) as a radiosensitizer in combination with low-dose TSEBT for Advanced CTCL: Clinical observations and experimental findings.

Autor: Oymanns, M. (AUTHOR), Greve, B. (AUTHOR), Daum-Marzian, M. (AUTHOR), Abu-Dawud, R. (AUTHOR), Motiei, M. (AUTHOR), Eich, H.T. (AUTHOR), Elsayad, K. (AUTHOR), Assaf, C. (AUTHOR)
Zdroj: European Journal of Cancer. 2024 Supplement 2, Vol. 211, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: